Protective effects of bone marrow mononuclear cell therapy on lung and heart in an elastase-induced emphysema model

Respiratory Physiology and Neurobiology

Volumn 182, Issue 1, 2012, Pages 26-36

  Cruz, Fernanda F ^a   Antunes, Mariana A ^a   Abreu, Soraia C ^a   Fujisaki, Lívia C ^a   Silva, Johnatas D ^a   Xisto, Débora G ^a   Maron Gutierrez, Tatiana ^a   Ornellas, Debora S ^a   Sá, Vanessa K ^b   Rocha, Nazareth N ^c   Capelozzi, Vera L ^b   Morales, Marcelo M ^a   Rocco, Patricia R M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Cardiovascular function; Elastase; Emphysema; Remodeling; Stem cells

Indexed keywords

CASPASE 3; COLLAGEN FIBER; MESSENGER RNA; PANCREATIC ELASTASE; PLATELET DERIVED GROWTH FACTOR; SODIUM CHLORIDE; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL WALL; BONE MARROW CELL; BONE MARROW DERIVED MONONUCLEAR CELL THERAPY; CELL THERAPY; CONTROLLED STUDY; DRUG INSTILLATION; ELASTOLYSIS; EMPHYSEMA; FEMALE; GENE EXPRESSION; HEART PROTECTION; HEART RIGHT VENTRICLE HYPERTROPHY; IMMUNOMODULATION; LUNG; LUNG ALVEOLUS CELL; LUNG ALVEOLUS WALL; LUNG BLOOD VESSEL; LUNG PARENCHYMA; MALE; MONONUCLEAR CELL; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION;

AIRWAY REMODELING; ANALYSIS OF VARIANCE; ANIMALS; BONE MARROW CELLS; CASPASE 3; ECHOCARDIOGRAPHY; EMPHYSEMA; FEMALE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES, MONONUCLEAR; LUNG; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; PANCREATIC ELASTASE; PULMONARY HEART DISEASE; RANDOM ALLOCATION;

EID: 84861670869     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2012.01.002     Document Type: Article

References (57)

1. Abdollahi A., Li M., Ping G., Plathow C., Domhan S., Kiessling F., Lee L.B., McMahon G., Gröne H.J., Lipson K.E., Huber P.E. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J. Exp. Med. 2005, 201:925-935.
2. Abreu S.C., Antunes M.A., Maron-Gutierrez T., Cruz F.F., Carmo L.G., Ornellas D.S., Junior H.C., Absaber A.M., Parra E.R., Capelozzi V.L., Morales M.M., Rocco P.R. Effects of bone marrow-derived mononuclear cells on airway and lung parenchyma remodeling in a murine model of chronic allergic inflammation. Respir. Physiol. Neurobiol. 2011, 175:153-163.
3. Abreu S.C., Antunes M.A., Pelosi P., Morales M.M., Rocco P.R.M. Mechanisms of cellular therapy in respiratory diseases. Intens. Care Med. 2011, 37:1421-1431.
4. Agusti A.G., Noguera A., Sauleda J., Sala E., Pons J., Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur. Respir. J. 2003, 21:347-360.
5. Antunes M.A., Rocco P.R. Elastase-induced pulmonary emphysema: insights from experimental models. An. Acad. Bras. Cienc. 2011, Epub ahead of print.
6. Araújo I.M., Abreu S.C., Maron-Gutierrez T., Cruz F., Fujisaki L., Carreira H., Ornellas F., Ornellas D., Vieira-de-Abreu A., Castro-Faria-Neto H.C., Muxfeldt Ab'Saber A., Teodoro W.R., Diaz B.L., Peres Dacosta C., Capelozzi V.L., Pelosi P., Morales M.M., Rocco P.R. Bone marrow-derived mononuclear cell therapy in experimental pulmonary and extrapulmonary acute lung injury. Crit. Care Med. 2010, 38:1733-1741.
7. Arunachalam G., Sundar I.K., Hwang J.W., Yao H., Rahman I. Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD. J. Inflam. (Lond) 2010, 22:7-34.
8. Barbera J.A., Peinado V.I., Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur. Respir. J. 2003, 21:892-905.
9. Barnes P.J., Stockley R.A. COPD: current therapeutic interventions and future approaches. Eur. Respir. J. 2005, 25:1084-1106.
10. Barr R.G., Bluemke D.A., Ahmed F.S., Carr J.J., Enright P.L., Hoffman E.A., Jiang R., Kawut S.M., Kronmal R.A., Lima J.A., Shahar E., Smith L.J., Watson K.E. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N. Engl. J. Med. 2010, 362:217-227.
11. 34+ cells are decreased in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2006, 3:537-538.
12. Brusselle G.G., Joos G.F., Bracke K.R. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011, 378:1015-1026.
13. Churg A., Zhou S., Wright J.L. Matrix metalloproteases in COPD. Eur. Respir. J. 2011, Epub ahead of print.
14. Cottin V., Nunes H., Brillet P.Y., Delaval P., Devouassoux G., Tillie-Leblond I., Israel-Biet D., Court-Fortune I., Valeyre D., Cordier J.F. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur. Respir. J. 2005, 26:586-593.
15. Doorn J., Moll G., Le Blanc K., van Blitterswijk C., De Boer J. Therapeutic applications of mesenchymal stromal cells; paracrine effects and potential improvements. Tissue Eng. Part B 2011, Epub ahead of print.
16. Dunnill M.S. Evaluation of a simple method of sampling the lung for quantitative histological analysis. Thorax 1964, 19:443-448.
17. Fabbri L.M., Luppi F., Beghe B., Rabe K.F. Update in chronic obstructive pulmonary disease 2005. Am. J. Respir. Crit. Care Med. 2006, 173:1056-1065.
18. Fabbri L.M., Luppi F., Beghe B., Rabe K.F. Complex chronic comorbidities of COPD. Eur. Respir. J. 2008, 31:204-212.
19. Fehrenbach H., Kasper M., Haase M., Schuh D., Muller M. Differential immunolocalization of VEGF in rat and human adult lung, and in experimental rat lung fibrosis: light, fluorescence, and electron microscopy. Anat. Rec. 1999, 254:61-73.
20. Fullmer H.M., Sheetz J.H., Narkates A.J. Oxytalan connective tissue fibers: a review. J. Oral Pathol. 1974, 3:291-316.
21. Gupta N., Su X., Popov B., Lee J.W., Serikov V., Matthay M.A. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J. Immunol. 2007, 179:1855-1863.
22. Hamakawa H., Bartolak-Suki E., Parameswaran H., Majumdar A., Lutchen K.R., Suki B. Structure-function relations in an elastase-induced mouse model of emphysema. Am. J. Respir. Cell Mol. Biol. 2010.
23. Hattori K., Dias S., Heissig B., Hackett N.R., Lyden D., Tateno M., Hicklin D.J., Zhu Z., Witte L., Crystal R.G., Moore M.A., Rafii S. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Med. 2001, 193:1005-1014.
24. Hoyle G.W., Li J., Finkelstein J.B., Eisenberg T., Liu J.Y., Lasky J.A., Athas G., Morris G.F., Brody A.R. Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. Am. J. Pathol. 1999, 154:1763-1775.
25. Huertas A., Testa U., Riccioni R., Petrucci E., Riti V., Savi D., Serra P., Bonsignore M.R., Palange P. Bone marrow-derived progenitors are greatly reduced in patients with severe COPD and low-BMI. Respir. Physiol. Neurobiol. 2010, 170:23-31.
26. Huertas A., Palange P. COPD: a multifactorial systemic disease. Ther. Adv. Respir. Dis. 2011, 5:217-224.
27. Huh J.W., Kim S.Y., Lee J.H., Lee J.S., Ta Q.V., Kim M.J., Oh Y.M., Lee Y.S., Lee S.D. Bone marrow cells repair cigarette smoke-induced emphysema in rats. Am. J. Physiol. Lung Cell Mol. Physiol. 2011, 301:255-266.
28. Jorgensen K., Muller M.F., Nel J., Upton R.N., Houltz E., Ricksten S.E. Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study. Chest 2007, 131:1050-1057.
29. Katsha A.M., Ohkouchi S., Xin H., Kanehira M., Sun R., Nukiwa T., Saijo Y. Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol. Ther. 2011, 19:196-203.
30. Krause D.S. Bone marrow-derived cells and stem cells in lung repair. Proc. Am. Thorac. Soc. 2008, 5:323-327.
31. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J., Solomon S., Spencer K.T., St John Sutton M., Stewart W. Recommendations for chamber quantification. Eur. J. Echocardiogr. 2006, 7:79-108.
32. Liebow A.A. Pulmonary emphysema with special reference to vascular changes. Am. Rev. Respir. Dis. 1959, 80:67-93.
33. Lolmede K., Campana L., Vezzoli M., Bosurgi L., Tonlorenzi R., Clementi E., Bianchi M.E., Cossu G., Manfredi A.A., Brunelli S., Rovere-Querini P. Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. J. Leukocyte Biol. 2009, 85:779-787.
34. Luthje L., Raupach T., Michels H., Unsold B., Hasenfuss G., Kogler H., Andreas S. Exercise intolerance and systemic manifestations of pulmonary emphysema in a mouse model. Respir. Res. 2009, 10:7.
35. Mannino D.M., Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2007, 4:502-506.
36. Maron-Gutierrez T., Castiglione R.C., Xisto D.G., Oliveira M.G., Cruz F.F., Peçanha R., Carreira-Junior H., Ornellas D.S., Moraes M.O., Takiya C.M., Rocco P.R., Morales M.M. Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis. Eur. Respir. J. 2011, 37:1217-1225.
37. Morty R.E., Konigshoff M., Eickelberg O. Transforming growth factor-beta signaling across ages: from distorted lung development to chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2009, 6:607-613.
38. Oliveira G.P., Oliveira M.B., Santos R.S., Lima L.D., Dias C.M., Ab' Saber A.M., Teodoro W.R., Capelozzi V.L., Gomes R.N., Bozza P.T., Pelosi P., Rocco P.R. Intravenous glutamine decreases lung and distal organ injury in an experimental model of abdominal sepsis. Crit. Care 2009, 13:R74.
39. Ortiz L.A., Dutreil M., Fattman C., Pandey A.C., Torres G., Go K., Phinney D.G. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:11002-11007.
40. Oskowitz A., McFerrin H., Gutschow M., Carter M.L., Pochampally R. Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem Cell Res. 2011, 6:215-225.
41. Prota L.F., Lassance R.M., Maron-Gutierrez T., Castiglione R.C., Garcia C.S., Santana M.C., Souza-Menezes J., Abreu S.C., Samoto V., Santiago M.F., Capelozzi V.L., Takiya C.M., Rocco P.R., Morales M.M. Bone marrow mononuclear cell therapy led to alveolar-capillary membrane repair, improving lung mechanics in endotoxin-induced acute lung injury. Cell Transplant. 2010, 19:965-971.
42. Rabe K.F., Wedzicha J.A. Controversies in treatment of chronic obstructive pulmonary disease. Lancet 2011, 378:1038-1047.
43. Rasmusson I. Immune modulation by mesenchymal stem cells. Exp. Cell Res. 2006, 312:2169-2179.
44. Rojas M., Xu J., Woods C.R., Mora A.L., Spears W., Roman J., Brigham K.L. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am. J. Respir. Cell Mol. Biol. 2005, 33:145-152.
45. Sadat S., Gehmert S., Song Y.H., Yen Y., Bai X., Gaiser S., Klein H., Alt E. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem. Biophys. Res. Commun. 2007, 363:674-679.
46. Schweitzer K.S., Johnstone B.H., Garrison J., Rush N.I., Cooper S., Traktuev D.O., Feng D., Adamowicz J.J., Van Demark M., Fisher A.J., Kamocki K., Brown M.B., Presson R.G., Broxmeyer H.E., March K.L., Petrache I. Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am. J. Respir. Crit. Care Med. 2011, 183:215-225.
47. Shigemura N., Okumura M., Mizuno S., Imanishi Y., Nakamura T., Sawa Y. Autologous transplantation of adipose tissue-derived stromal cells ameliorates pulmonary emphysema. Am. J. Transplant. 2006, 6:2592-2600.
48. Snider G.L. Distinguishing among asthma, chronic bronchitis, and emphysema. Chest 1985, 87:35S-39S.
49. Sutherland E.R., Cherniack R.M. Management of chronic obstructive pulmonary disease. N. Engl. J. Med. 2004, 350:2689-2697.
50. Taraseviciene-Stewart L., Voelkel N.F. Molecular pathogenesis of emphysema. J. Clin. Invest. 2008, 118:394-402.
51. Weibel E.R. Morphometry: stereological theory and practical methods. Models of Lung Disease-Microscopy and Structural Methods 1990, 199-247. Marcel Dekker, New York. J. Gil (Ed.).
52. Xu J., Woods C.R., Mora A.L., Joodi R., Brigham K.L., Iyer S., Rojas M. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 293:L131-L141.
53. Yamada M., Kubo H., Kobayashi S., Ishizawa K., Numasaki M., Ueda S., Suzuki T., Sasaki H. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J. Immunol. 2004, 172:1266-1272.
54. Yamashita N., Tashimo H., Ishida H., Matsuo Y., Arai H., Nagase H., Adachi T., Ohta K. Role of insulin-like growth factor-I in allergen-induced airway inflammation and remodeling. Cell Immunol. 2005, 235:85-91.
55. Yoshida H., Kitaichi T., Urata M., Kurobe H., Kanbara T., Motoki T., Kitagawa T. Syngeneic bone marrow mononuclear cells improve pulmonary arterial hypertension through vascular endothelial growth factor upregulation. Ann. Thorac. Surg. 2009, 88:418-424.
56. Zhen G., Liu H., Gu N., Zhang H., Xu Y., Zhang Z. Mesenchymal stem cells transplantation protects against rat pulmonary emphysema. Front. Biosci. 2008, 13:3415-3422.
57. Zhen G., Xue Z., Zhao J., Gu N., Tang Z., Xu Y., Zhang Z. Mesenchymal stem cell transplantation increases expression of vascular endothelial growth factor in papain-induced emphysematous lungs and inhibits apoptosis of lung cells. Cytotherapy 2010, 12:605-614.